NasdaqCM - Nasdaq Real Time Price USD

ZeroStack Corp. (ZSTK)

2.7700 -0.1500 (-5.14%)

At close: November 2 at 4:00:00 PM EST

3.0000 +0.2300 (+8.30%)

Overnight: 1:00:22 AM EST

Chart Range Bar

Advanced Chart

AlphaSpace Chart

Loading chart for ZSTK

Previous Close 2.9200
Open 2.9200
Bid 2.9200 x 100
Ask 3.0400 x 400
Day's Range 2.6100 - 2.9200
52 Week Range 1.3200 - 15.0410
Volume 6,464
Avg. Volume 484,621
Market Cap (intraday) 60.378M
Beta (5Y Monthly) 2.08
PE Ratio (TTM) --
EPS (TTM) -43.6500
Earnings Date --
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est 11.00

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

zerostack.ai

Full Time Employees

December 31

Fiscal Year Ends

Financial Services

Sector

Asset Management

Industry

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZSTK

55.75%

S&P 500 (^GSPC)

10.17%

1-Year Return

ZSTK

70.93%

S&P 500 (^GSPC)

10.25%

3-Year Return

ZSTK

91.93%

S&P 500 (^GSPC)

74.66%

5-Year Return

ZSTK

99.92%

S&P 500 (^GSPC)

62.86%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 13.66M

Earnings -24.61M

Profit Margin -180.22%

FY25

FY26

-100M

-80M

-60M

-40M

-20M

-1000.0%

-800.0%

-600.0%

-400.0%

-200.0%

0.0%

Analyst Price Targets

11.00

11.00 Average

2.7700 Current

11.00 High

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-33.36%
Return on Equity (ttm)

-1,959.59%
Revenue (ttm)

40.03M
Net Income Avi to Common (ttm)

-174.8M
Diluted EPS (ttm)

-43.6500

Balance Sheet and Cash Flow

Total Cash (mrq)

2.64M
Total Debt/Equity (mrq)

19.95%
Levered Free Cash Flow (ttm)

-179.75k

IMCC IM Cannabis Corp.

0.7486 0.00%

ENSC Ensysce Biosciences, Inc.

0.3999 +4.66%

VRPX Virpax Pharmaceuticals, Inc.

0.0003 -62.50%

KTTA Pasithea Therapeutics Corp.

0.3680 0.00%

DBGI Digital Brands Group, Inc.

0.5110 -8.70%

U.S. markets open in 20m

ZeroStack Corp. (ZSTK)

-11.50%

-43.00%

-46.64%

-55.75%

-70.93%

-99.92%

-99.94%

ZeroStack Corp. Overview Asset Management / Financial Services

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch